Business Context and Reporting Period
Company: Revelation Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 9, 2022 (Event Date)
Reporting Period: Single event disclosure; no financial period covered.
Business Context: The Company is an emerging growth company incorporated in Delaware, focused on biosciences. This filing serves to disclose a corporate presentation update intended for the BIO CEO Conference scheduled for February 14, 2022.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding a corporate presentation and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The sole material event is the release of an updated corporate presentation by CEO James Rolke.
Guidance, Outlook, and Risks
- Management Commentary: The Company uploaded an updated corporate presentation to be delivered at the BIO CEO Conference. The content of this presentation is attached as Exhibit 99.1.
- Legal Status of Information: In accordance with General Instruction B.2 of Form 8-K, the information in Item 7.01 and Exhibit 99.1 is deemed "furnished" and not "filed" for purposes of Section 18 of the Exchange Act. It is not incorporated by reference into other filings unless expressly stated.
- Risks and Contingencies: No specific risks or contingencies are detailed in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Updated Corporate Presentation) for specific strategic updates or data not included in this summary.
- Verify the Company's status as an emerging growth company and its implications for financial reporting standards.
- Confirm the trading symbols for the Company's securities: Units (REVBU), Common Stock (REVB), and Redeemable Warrants (REVBW) on The Nasdaq Stock Market LLC.
- Note that the information furnished in this 8-K is not legally "filed" and may not be relied upon as incorporated by reference in other SEC filings without specific citation.